Career summary
Greg is JLL’s regional Life Sciences Tenant Advisory Lead for Southern California, with 28+ years of commercial broker experience. He has become one of San Diego’s leading lab space site selection and negotiation experts. He is known as being a tenant advocate specializing in advising life science companies with their real estate needs and strategic planning. Transaction specialties include portfolio management, global site selection, lease negotiations, build-to-suits, structured finance, lease, sublease and sale dispositions and fee simple acquisitions. Greg is an expert at helping life science users secure lab/R&D/mfg solutions and has achieved over $5+ billion in transaction experience as well as over 5 million square feet in negotiated laboratory transactions.
Prior to JLL, Greg led the Cushman & Wakefield’s National Life Sciences Advisory Group, where he specialized primarily in tenant representation. As the Life Sciences Advisory Group leader, he helped lead C&W’s local and national life sciences clients in their laboratory, office, and manufacturing needs. Greg was awarded the C&W #1 Producer San Diego 2021, Top 10 Americas 2021, and was a C&W San Diego Top 10 Producer 2008-2022.
Select Transactions (Last 5 years):
2022, Bristol Myers Squibb | 427,000 sf | new HQ / R&D |Build-to-suit
2021, Mannkind | 265,000 sf | sale/leaseback ($100M)
2021, Prometheus Labs | 110,000 sf | renewal/recast
2020, Turning Point Thx | 185,000 sf | new HQ / R&D | Build-to-suit
2020, Prometheus Biosciences | 55,000 sf | new HQ / R&D | custom
2020, RayzeBio | 27,000 sf | new HQ/R&D |custom from shell
2020, 8five8 Therapeutics | 20,000 sf | new HQ / R&D | custom from shell
2019, Synthetic Genomics | 45,000 sf | new HQ / R&D | custom from shell
2019, Nitto Biopharma | 60,000 sf | expansion
2019, Regulus |25,000 sf | right-sizing | sublease
2017, Takeda | 164,000 sf | new HQ / R&D | Build-to-suit
2016, Dexcom | 500,000+ sf| various transactions
2015, Lilly | 304,000 sf | new HQ / R&D | Build-to-suit
Specialties:
- Exclusively Focused on Lab Space- Leasing/Sales
- Cost reduction and facilities optimization
- Long-term strategic planning and strategic advisory
- Lease renewals/restructuring
- Feasibility/Transaction Analysis
- Scaling, outsourcing, and portfolio management
